Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 56 of 120)
- Relevance
  Sort by

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
42 Pages
Global

From

€3083EUR$3,500USD£2,710GBP

Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Targeted, Hormonal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Cancer Type (Hormone Receptor, HER2+), And Segment Forecasts, 2023-2030

 Report
June 2023
180 Pages
Global

From

€5240EUR$5,950USD£4,606GBP

Fungal Keratitis Treatment - Global Strategic Business Report

 Report
December 2025
484 Pages
Global

From

€5152EUR$5,850USD£4,529GBP

Contract Injectable Packaging Trends in the Bio/Pharma Industry

 Report
August 2022
96 Pages
Global

From

€4399EUR$4,995USD£3,867GBP

Non-Hodgkin Lymphoma (NHL) Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
November 2025
180 Pages
Global

From

€3963EUR$4,500USD£3,484GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Sexually Transmitted Diseases (STD) Treatment Market 2025-2029

 Report
July 2025
220 Pages
Global

From

€2202EUR$2,500USD£1,935GBP

Multiple Myeloma Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
198 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Ibrutinib Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Chronic Lymphocytic Leukemia Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
197 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Chronic Myelogenous Leukemia Therapeutics Market - Global Forecast 2025-2032

 Report
October 2025
182 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Nasal Drug Delivery Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

 Drug Pipelines
June 2022
101 Pages
Global

From

€13207EUR$14,995USD£11,609GBP

Diffuse Large B-cell Lymphoma Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Follicular Lymphoma Treatment Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Mantle Cell Lymphoma Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Non Hodgkin Lymphoma (NHL) Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Biosimilar Interleukins Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Bipolar Disorder Therapeutics Market 2024-2028

 Report
November 2023
161 Pages
Global

From

€2202EUR$2,500USD£1,935GBP

Leukemia Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
181 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Acute Myeloid Leukemia Therapeutics Market - Global Forecast 2025-2032

 Report
November 2025
180 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

2,397 Results (Page 56 of 120)
- 1
- 54
- 55
- 56
- 57
- 58

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.